| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000017817 |
| Receipt No. | R000020573 |
| Official scientific title of the study | A recent survey of postoperative nausea and vomiting |
| Date of disclosure of the study information | 2015/06/08 |
| Last modified on | 2016/07/09 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | A recent survey of postoperative nausea and vomiting | |
| Title of the study (Brief title) | A recent survey of postoperative nausea and vomiting | |
| Region |
|
|
| Condition | ||||
| Condition | Patients undergone operation | |||
| Classification by specialty |
|
|||
| Classification by malignancy | Others | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | Prospective study of incidence of PONV |
| Basic objectives2 | Others |
| Basic objectives -Others | Prospective study of risk factors for PONV |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Others |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | The incidence of PONV in 24hr after operation |
| Key secondary outcomes | The risk factors for PONV |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Every postoperative patient who have undergone a surgical procedure under anesthetic management by a anesthesiologist | |||
| Key exclusion criteria | Patients postoperatively managed with artificial ventilation, patients maintained with more than 2 kinds of anesthetic, patients underwent electricconvulsive therapy | |||
| Target sample size | 1000 | |||
| Research contact person | |
| Name of lead principal investigator | Maiko HOSHIKA |
| Organization | Nagoya City University Graduate School of Medical Sciences |
| Division name | Department of Anesthesiology and Intensive Care Medicine |
| Address | 1-Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, JAPAN |
| TEL | 052-851-5511 |
| myconjar@yahoo.co.jp | |
| Public contact | |
| Name of contact person | Maiko HOSHIKA |
| Organization | Nagoya City University Graduate School of Medical Sciences |
| Division name | Department of Anesthesiology and Intensive Care Medicine |
| Address | 1-Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, JAPAN |
| TEL | 052-851-5511 |
| Homepage URL | |
| myconjar@yahoo.co.jp | |
| Sponsor | |
| Institute | Nagoya City University Graduate School of Medical Sciences |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Nagoya city east medical center, Kainan hospital, Okazaki city hospital |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 名古屋市東部医療センター(愛知県)、JA厚生連海南病院(愛知県)、岡崎市民病院(愛知県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Prospective study, Incidence of PONV and Risk for PONV, over 1000 cases |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020573 |